Chimera Investment Analyst Price Targets

Wall Street analyst price targets and consensus rating for Chimera Investment (CIM).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

1Buy

3Hold

Consensus RatingBuy# Analysts4Avg. Consensus PT$15Upside to Avg. PT+72.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 6, 2026	Keefe, Bruyette & Woods	Bose George	PT Cut	Market Perform	$15→$14
Jun 3, 2026	RBC Capital	Kenneth S. Lee	Maintained	Sector Perform	$14
Nov 18, 2025	UBS	Douglas Harter	PT Cut	Buy	$16→$16
Jul 10, 2025	UBS	Douglas Harter	PT Raise	Buy	$15→$16
Jul 10, 2025	Keefe, Bruyette & Woods	Bose George	PT Cut	Market Perform	$17→$15
May 14, 2025	UBS	Douglas Harter	Upgrade	Neutral→Buy	$12→$15
Jan 23, 2025	JMP Securities	Aaron Hecht	Maintained	Market Perform	—
Aug 8, 2024	Keefe, Bruyette & Woods	Bose George	PT Raise	Market Perform	$15→$16
Jul 10, 2024	Keefe, Bruyette & Woods	Bose George	Maintained	Market Perform	$15
Dec 6, 2023	UBS	Douglas Harter	Initiate	Neutral	$17

Analyst Ratings News

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $14

Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the price target from $15 to $14.

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields

Investors seek dividend-yielding stocks during market turbulence. Benzinga provides latest analyst ratings and accurate analysts for high-yield stocks in finance.

Avi Kapoor

PRO
RBC Capital Reiterates Sector Perform on Chimera Investment, Maintains $14 Price Target

RBC Capital analyst Kenneth S. Lee reiterates Chimera Investment (NYSE:CIM) with a Sector Perform and maintains $14 price target.

Benzinga Newsdesk

Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields

Avi Kapoor

PRO
UBS Maintains Buy on Chimera Investment, Raises Price Target to $16

UBS analyst Douglas Harter maintains Chimera Investment (NYSE:CIM) with a Buy and raises the price target from $15 to $16.

Benzinga Newsdesk

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $15

Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the price target from $16.5 to $15.

Benzinga Newsdesk

Chimera Investment Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

Chimera Investment Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $14

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields

PRO
RBC Capital Reiterates Sector Perform on Chimera Investment, Maintains $14 Price Target

Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields

PRO
UBS Maintains Buy on Chimera Investment, Raises Price Target to $16

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $15

People Also Watch

People Also Watch

Chimera Investment Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

Chimera Investment Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROKeefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $14

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields

PRORBC Capital Reiterates Sector Perform on Chimera Investment, Maintains $14 Price Target

Wall Street's Most Accurate Analysts Spotlight On 3 Financial Stocks Delivering High-Dividend Yields

PROUBS Maintains Buy on Chimera Investment, Raises Price Target to $16

PROKeefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $15

People Also Watch

People Also Watch

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $14

PRO
RBC Capital Reiterates Sector Perform on Chimera Investment, Maintains $14 Price Target

PRO
UBS Maintains Buy on Chimera Investment, Raises Price Target to $16

PRO
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $15